Avior Wealth Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VAXX
SWM
XT
CGL
GT
FDCDDQ
RF
Avior Wealth Management's VAXX Position: Q2 2024 in Review
Avior Wealth Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 2,056 shares — an estimated $1.48K sold.
Avior Wealth Management first reported a position in VAXX in Q3 2023 and held it in 3 quarters. The position peaked at $2.81K in Q3 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.
- Avior Wealth Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
- Avior Wealth Management sold 2,056 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1.48K.
- Avior Wealth Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2023 and held it in 3 quarters.
- Avior Wealth Management's Vaxxinity, Inc. Class A Common Stock position peaked at $2.81K in Q3 2023.
- 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.
Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.